HK1063787A1 - Novel ligand for nicotinic acetylcholine receptorsuseful in therapy - Google Patents

Novel ligand for nicotinic acetylcholine receptorsuseful in therapy

Info

Publication number
HK1063787A1
HK1063787A1 HK04106588A HK04106588A HK1063787A1 HK 1063787 A1 HK1063787 A1 HK 1063787A1 HK 04106588 A HK04106588 A HK 04106588A HK 04106588 A HK04106588 A HK 04106588A HK 1063787 A1 HK1063787 A1 HK 1063787A1
Authority
HK
Hong Kong
Prior art keywords
therapy
receptorsuseful
nicotinic acetylcholine
novel ligand
ligand
Prior art date
Application number
HK04106588A
Other languages
English (en)
Inventor
Eifion Phillips
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1063787A1 publication Critical patent/HK1063787A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
HK04106588A 2001-06-01 2004-09-01 Novel ligand for nicotinic acetylcholine receptorsuseful in therapy HK1063787A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29520601P 2001-06-01 2001-06-01
PCT/SE2002/001031 WO2002096912A1 (en) 2001-06-01 2002-05-29 Novel ligand for nicotinic acetylcholine receptors useful in therapy

Publications (1)

Publication Number Publication Date
HK1063787A1 true HK1063787A1 (en) 2005-01-14

Family

ID=23136711

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04106588A HK1063787A1 (en) 2001-06-01 2004-09-01 Novel ligand for nicotinic acetylcholine receptorsuseful in therapy

Country Status (19)

Country Link
EP (1) EP1397366B1 (xx)
JP (1) JP2004532877A (xx)
KR (1) KR20040003021A (xx)
CN (1) CN1294136C (xx)
AT (1) ATE353332T1 (xx)
BR (1) BR0210075A (xx)
CA (1) CA2455341A1 (xx)
DE (1) DE60218032T2 (xx)
DK (1) DK1397366T3 (xx)
ES (1) ES2280538T3 (xx)
HK (1) HK1063787A1 (xx)
IL (1) IL158735A0 (xx)
MX (1) MXPA03010996A (xx)
NO (1) NO20035333D0 (xx)
NZ (1) NZ529426A (xx)
PT (1) PT1397366E (xx)
SI (1) SI1397366T1 (xx)
WO (1) WO2002096912A1 (xx)
ZA (1) ZA200308779B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
DE60328010D1 (de) 2002-04-18 2009-07-30 Astrazeneca Ab Heterocyclische verbindungen
CA2482311C (en) * 2002-04-18 2009-12-08 Astrazeneca Ab Furyl compounds
JP4511196B2 (ja) * 2002-04-18 2010-07-28 アストラゼネカ・アクチエボラーグ チエニル化合物
JP4855264B2 (ja) 2003-10-21 2012-01-18 アストラゼネカ・アクチエボラーグ スピロフロピリジンアリール誘導体
TW200813067A (en) * 2006-05-17 2008-03-16 Astrazeneca Ab Nicotinic acetylcholine receptor ligands
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
EA201001889A1 (ru) 2008-06-20 2011-08-30 Астразенека Аб Производные дибензотиазепина и их применение
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
ES2746850T3 (es) 2010-05-17 2020-03-09 Forum Pharmaceuticals Inc Formulaciones farmacéuticas que comprenden formas cristalinas de clorhidrato de (R)-7-cloro-N-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida monohidratado
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
MX358512B (es) 2012-05-08 2018-08-24 Forum Pharmaceuticals Inc Uso de (r)-7cloro-n-(quinuclidin-3-il) benzo[b] tiofeno-2-carboxamida o una sal farmacéuticamente aceptable de la misma para preparar una composición farmacéutica en el tratamiento de una disfunción cognitiva.
GB201209587D0 (en) 2012-05-30 2012-07-11 Takeda Pharmaceutical Therapeutic compounds
WO2014122474A1 (en) 2013-02-07 2014-08-14 Takeda Pharmaceutical Company Limited Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
CA2914263C (en) 2013-06-21 2021-05-18 Takeda Pharmaceutical Company Limited 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
GB201314286D0 (en) 2013-08-08 2013-09-25 Takeda Pharmaceutical Therapeutic Compounds
GB201318222D0 (en) 2013-10-15 2013-11-27 Takeda Pharmaceutical Novel compounds
GB201320905D0 (en) 2013-11-27 2014-01-08 Takeda Pharmaceutical Therapeutic compounds
TW201613864A (en) 2014-02-20 2016-04-16 Takeda Pharmaceutical Novel compounds
GB201616839D0 (en) 2016-10-04 2016-11-16 Takeda Pharmaceutical Company Limited Therapeutic compounds
GB201619514D0 (en) 2016-11-18 2017-01-04 Takeda Pharmaceuticals Co Novel compounds
JP2021138648A (ja) 2020-03-04 2021-09-16 武田薬品工業株式会社 経口固形製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002500652A (ja) * 1997-05-30 2002-01-08 ニューロサーアチ・アクティーゼルスカブ スピロ−キヌクリジン誘導体、その製造方法及びその使用方法
AR013184A1 (es) * 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) * 1999-01-15 1999-01-15 Astra Ab New compounds

Also Published As

Publication number Publication date
MXPA03010996A (es) 2004-02-27
BR0210075A (pt) 2004-08-17
NZ529426A (en) 2005-07-29
CN1294136C (zh) 2007-01-10
ZA200308779B (en) 2005-02-11
EP1397366B1 (en) 2007-02-07
ATE353332T1 (de) 2007-02-15
ES2280538T3 (es) 2007-09-16
DE60218032T2 (de) 2007-08-16
WO2002096912A1 (en) 2002-12-05
PT1397366E (pt) 2007-04-30
NO20035333D0 (no) 2003-11-28
CN1512995A (zh) 2004-07-14
KR20040003021A (ko) 2004-01-07
EP1397366A1 (en) 2004-03-17
CA2455341A1 (en) 2002-12-05
SI1397366T1 (sl) 2007-06-30
IL158735A0 (en) 2004-05-12
JP2004532877A (ja) 2004-10-28
DK1397366T3 (da) 2007-05-07
DE60218032D1 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
HK1063787A1 (en) Novel ligand for nicotinic acetylcholine receptorsuseful in therapy
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
DE60112974D1 (en) Carbolinderivate
CY1113054T1 (el) Παραγωγα διαμινης
HK1080470A1 (en) Heterocyclic compounds
YU6303A (sh) Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa
HK1079522A1 (en) Thienyl compounds
ZA200204667B (en) Hybrid slot machine.
EP1277754A4 (en) Imidazopyridine DERIVATIVES
ZA200608416B (en) Herbicidal composition
UA84712C2 (xx) N-заміщені піразоліламідилбензімідазоліли як c-kit інгібітори$n-замещенные пиразолиламидилбензимидазолилы как c-kit ингибиторы
DE60216233D1 (en) Carbolinderivate
TW200519111A (en) N3-substituted imidazopyridine C-KIT inhibitors
MXPA02012076A (es) Compuestos quimicos.
AU2001266575A1 (en) Chemical compounds
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
BR0103824A (pt) Vernizes em pó de pur foscos
TW200508199A (en) Novel compound
GB0018951D0 (en) Novel compounds
WO2002036557A3 (en) Fluoroborate salts comprising a reactive cation and uses thereof
GB0027705D0 (en) Novel compounds
MXPA05003315A (es) Un sistema de liberacion controlada que contiene temozolomida.
MXPA02012472A (es) Compuestos quimicos.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110529